116 related articles for article (PubMed ID: 35366766)
1. Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting ABCA1 and microRNA-33.
Ghaffari T; Moradi N; Chamani E; Ebadi Z; Fadaei R; Alizadeh-Fanalou S; Yarahmadi S; Fallah S
Curr Pharm Des; 2022; 28(16):1367-1372. PubMed ID: 35366766
[TBL] [Abstract][Full Text] [Related]
2. Captopril and Spironolactone Can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting microRNA-192 and microRNA-29a/b/c.
Ebadi Z; Moradi N; Kazemi Fard T; Balochnejadmojarrad T; Chamani E; Fadaei R; Fallah S
DNA Cell Biol; 2019 Oct; 38(10):1134-1142. PubMed ID: 31433203
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
Hofni A; El-Moselhy MA; Taye A; Khalifa MM
Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917
[TBL] [Abstract][Full Text] [Related]
4. Effects of curcumin and captopril on the functions of kidney and nerve in streptozotocin-induced diabetic rats: role of angiotensin converting enzyme 1.
Abd Allah ES; Gomaa AM
Appl Physiol Nutr Metab; 2015 Oct; 40(10):1061-7. PubMed ID: 26398443
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365
[TBL] [Abstract][Full Text] [Related]
6. Effects of HuoxueJiangtang decoction alone or in combination with metformin on renal function and renal cortical mRNA expression in diabetic nephropathy rats.
Liu X; Liu D; Shuai Y; Li H; Zhao H; Qu X; Chu S; Zhang X
Pharm Biol; 2020 Dec; 58(1):1123-1130. PubMed ID: 33191822
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats.
Akbar DH; Hagras MM; Amin HA; Khorshid OA
J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):103-15. PubMed ID: 23077081
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice.
Yin QH; Zhang R; Li L; Wang YT; Liu JP; Zhang J; Bai L; Cheng JQ; Fu P; Liu F
J Biol Chem; 2016 Dec; 291(51):26487-26501. PubMed ID: 27784780
[TBL] [Abstract][Full Text] [Related]
10. Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats.
Follansbee MH; Beyer KH; Griffith JW; Vesell ES
Pharmacology; 1997 May; 54(5):241-55. PubMed ID: 9380770
[TBL] [Abstract][Full Text] [Related]
11. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
Pechanova O; Matuskova J; Capikova D; Jendekova L; Paulis L; Simko F
Kidney Int; 2006 Jul; 70(1):170-6. PubMed ID: 16710350
[TBL] [Abstract][Full Text] [Related]
12. Role of Oxidative Stress and Reduced Endogenous Hydrogen Sulfide in Diabetic Nephropathy.
Hussain Lodhi A; Ahmad FU; Furwa K; Madni A
Drug Des Devel Ther; 2021; 15():1031-1043. PubMed ID: 33707940
[TBL] [Abstract][Full Text] [Related]
13. ABCA1 and ABCG1 expression in the small intestine of type 2 diabetic rats.
Lou J; Zhou H; Li C; Hu L; Lu X; Li J; Yao H; Li W; Zhang X; Xu M
Lab Med; 2014; 45(1):17-24. PubMed ID: 24719980
[TBL] [Abstract][Full Text] [Related]
14. Cellular cholesterol transport proteins in diabetic nephropathy.
Tsun JG; Yung S; Chau MK; Shiu SW; Chan TM; Tan KC
PLoS One; 2014; 9(9):e105787. PubMed ID: 25181357
[TBL] [Abstract][Full Text] [Related]
15. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
[TBL] [Abstract][Full Text] [Related]
16. [Renal angiotensin converting enzyme (ACE) expression in diabetic rats: the effect of ACE inhibitors].
Yoshikawa H
Nihon Jinzo Gakkai Shi; 1999 Aug; 41(5):486-92. PubMed ID: 10502942
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats.
Fujisawa G; Okada K; Muto S; Fujita N; Itabashi N; Kusano E; Ishibashi S
Kidney Int; 2004 Oct; 66(4):1493-502. PubMed ID: 15458443
[TBL] [Abstract][Full Text] [Related]
18. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai PB; Zhang L; Yang LY
Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
[TBL] [Abstract][Full Text] [Related]
19. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway.
Pang R; Gu D
Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721
[TBL] [Abstract][Full Text] [Related]
20. Effect of Picrorrhiza rhizoma extracts on early diabetic nephropathy in streptozotocin-induced diabetic rats.
Lee HS; Ku SK
J Med Food; 2008 Jun; 11(2):294-301. PubMed ID: 18598172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
